RecruitingNCT06504927

Biomarker Discovery in Lung Cancer - Malaysia


Sponsor

University of Malaya

Enrollment

400 participants

Start Date

Jan 16, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.


Eligibility

Min Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This study in Malaysia is looking for a blood-based biomarker — a measurable signal in the blood — that can help detect lung cancer at an early stage. It focuses on people who already have lung-related conditions (like COPD or small lung nodules) but have not been diagnosed with lung cancer, to see if a blood test can provide early warning. **You may be eligible if...** - You are 30 years or older - You have no previous history of any cancer - You have COPD or small lung nodules (under 11mm) that don't require biopsy - You are willing to provide blood samples and return for follow-up scans - You can provide your X-ray or low-dose CT (LDCT) scan results **You may NOT be eligible if...** - You have received chemotherapy, radiotherapy, or any cancer treatment - You are pregnant or breastfeeding - You are unwilling to sign consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Malaya Medical Centre

Kuala Lumpur, Malaysia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06504927


Related Trials